Natural killer cells act as an extrinsic barrier for in vivo reprogramming

dc.contributor.author
Melendez, Elena
dc.contributor.author
Chondronasiou, Dafni
dc.contributor.author
Mosteiro, Lluc
dc.contributor.author
Martínez de Villarreal, Jaime
dc.contributor.author
Fernández Alfara, Marcos
dc.contributor.author
Lynch, Cian J.
dc.contributor.author
Grimm, Dirk
dc.contributor.author
Real, Francisco X.
dc.contributor.author
Alcamí, José
dc.contributor.author
Climent Vidal, Núria
dc.contributor.author
Pietrocola, Federico
dc.contributor.author
Serrano Marugán, Manuel
dc.date.issued
2022-05-09T07:53:46Z
dc.date.issued
2022-05-09T07:53:46Z
dc.date.issued
2022-04-14
dc.date.issued
2022-05-06T10:17:27Z
dc.identifier
1477-9129
dc.identifier
https://hdl.handle.net/2445/185453
dc.identifier
6548062
dc.identifier
35420133
dc.description.abstract
The ectopic expression of transcription factors Oct4, Sox2, Klf4 and Myc (OSKM) enables reprogramming of differentiated cells into pluripotent embryonic stem cells. Methods based on partial and reversible in vivo reprogramming are a promising strategy for tissue regeneration and rejuvenation. However, little is known about the barriers that impair reprogramming in an in vivo context. We report that natural killer (NK) cells significantly limit reprogramming, both in vitro and in vivo. Cells and tissues at the intermediate states of reprogramming upregulate the expression of NK activating ligands, such as MULT1 and ICAM1. NK cells recognize and kill partially reprogrammed cells in a degranulation-dependent manner. Importantly, in vivo partial reprogramming is strongly reduced by adoptive transfer of NK cells, whereas it is significantly improved by depletion of NK cells. Notably, in the absence of NK cells, the pancreatic organoids derived from OSKM-expressing mice are remarkably large, suggesting the generation of cells with progenitor properties. We conclude that NK cells pose an important barrier for in vivo reprogramming, and this concept may apply to other contexts of transient cellular plasticity.
dc.format
12 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Company of Biologists Ltd
dc.relation
Reproducció del document publicat a: https://doi.org/10.1242/dev.200361
dc.relation
Development, 2022, vol.149, num. 8, p. dev200361
dc.relation
https://doi.org/10.1242/dev.200361
dc.relation
info:eu-repo/grantAgreement/EC/H2020/669622/EU//CELLPLASTICITY
dc.rights
cc by (c) Melendez, Elena et al., 2022
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
dc.subject
Cèl·lules mare embrionàries
dc.subject
Cèl·lules K
dc.subject
Sistema immunitari
dc.subject
Embryonic stem cells
dc.subject
Killer cells
dc.subject
Immune system
dc.title
Natural killer cells act as an extrinsic barrier for in vivo reprogramming
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.